|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
67,796,291 |
|
|
Direct
Value |
$156,124,463 |
|
|
Indirect Value
|
$362,246,186 |
|
|
Total
Shares |
71,480,988 |
|
|
Total
Value |
$518,370,649 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
0
|
Stock
price went up :
|
6
|
0
|
Stock
price went down : |
8
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
46.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-08-09 |
4 |
B |
$5.88 |
$4,341,386 |
I/I |
738,331 |
738,331 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-08-10 |
4 |
B |
$6.13 |
$1,604,031 |
I/I |
261,669 |
1,000,000 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-14 |
4 |
B |
$8.13 |
$1,788,600 |
I/I |
220,000 |
1,220,000 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-15 |
4 |
B |
$8.18 |
$1,985,319 |
I/I |
242,704 |
1,462,704 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-16 |
4 |
B |
$8.19 |
$1,437,509 |
I/I |
175,520 |
1,638,224 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-21 |
4 |
B |
$8.04 |
$454,075 |
I/I |
56,477 |
1,694,701 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-22 |
4 |
B |
$8.11 |
$447,234 |
I/I |
55,146 |
1,749,847 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-11-23 |
4 |
B |
$8.00 |
$1,328,800 |
I/I |
166,100 |
1,915,947 |
2.25 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2012-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,000,000 |
649,181 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,450,000 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-15 |
4 |
B |
$7.35 |
$3,142,720 |
I/I |
427,581 |
3,333,528 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-16 |
4 |
B |
$7.44 |
$2,566,130 |
I/I |
344,910 |
3,678,438 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-17 |
4 |
B |
$7.50 |
$2,242,553 |
I/I |
299,007 |
3,977,445 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-06-01 |
4 |
B |
$7.39 |
$732,201 |
I/I |
99,080 |
283,840 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-06-04 |
4 |
B |
$7.37 |
$660,691 |
I/I |
89,646 |
328,663 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-06-05 |
4 |
B |
$7.48 |
$40,863 |
I/I |
5,463 |
331,394 |
2.25 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2013-01-25 |
4 |
B |
$0.00 |
$0 |
I/I |
6,000,000 |
1,849,181 |
1.42 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
3,470,000 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2013-08-13 |
4 |
A |
$0.00 |
$1,579,760 |
I/I |
1,880,737 |
73,668 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2013-08-13 |
4 |
A |
$0.00 |
$1,501,600 |
I/I |
1,696,140 |
76,611 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2013-08-13 |
4 |
A |
$0.00 |
$4,788,448 |
I/I |
5,399,630 |
131,081 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2013-10-15 |
4 |
OE |
$4.94 |
$49,400 |
D/D |
10,000 |
3,480,000 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2014-03-27 |
4 |
B |
$25.72 |
$6,249,986 |
I/I |
243,001 |
243,001 |
2.64 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2014-05-09 |
4 |
B |
$13.42 |
$202,481 |
I/I |
15,088 |
779,294 |
2.64 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2014-05-09 |
4/A |
B |
$13.42 |
$233,239 |
I/I |
17,248 |
129,794 |
2.64 |
- |
|
271 Records found
|
|
Page 4 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|